World CDx Boston 2017

Date: 2017/10/17 - 2017/10/19

Location: Boston, MA

Additional info: Hilton Boston/Woburn

Country: United States

Advancing the Development & Clinical Utility of Liquid Biopsies


Dan Edelstein, Ph.D.,
Director, Clinical Marketing & New Technology, Sysmex Inostics Inc.

"The OncoBEAM™ Platform: Global Implementation of a Highly Sensitive Liquid Biopsy Technology for Clinical Trials and Clinical Practice"

• The OncoBEAM™ Platform has been validated across cancer types with sensitivity of around 0.02% MF
• Sensitivity matters in liquid biopsies for accurate biomarker detection and patient classification
Sysmex Inostics OncoBEAM™ assays are available for CRO services and/or Patient testing globally

Tags: Events

Back to list